Reassessment of reimbursement status of ATC-groups C01, C04 and C05

18 December 2006

At its meetings on 19 September and 7 November 2006, the Reimbursement Committee discussed the reimbursement status of medicinal products in ATC-groups:

  • Medicinal products for cardiac therapy (C01)
  • Peripheral vasodilators (C04)
  • Vasoprotectives (C05)

Based on its discussions, the Reimbursement Committee is going to make a recommendation for the Danish Medicines Agency.

In the fact box to the right, you can find a link to the documents from Reimbursement Committee meetings (in Danish only).

For further information, please contact Nikolai Laursen on tel.: +45 4488 9102 or the Reimbursement Department, Send an email .

The Danish Medicines Agency, 29 November 2006

Did you get answers to your questions?

Please tell us how we can improve our website? Please note that we do not answer questions asked via this feature.